4CMenB Vaccination Effective Against Invasive Meningococcal Disease in Children Under 5

THURSDAY, Feb. 2, 2023 -- Complete vaccination with the four-component, protein-based meningococcal serogroup B vaccine (4CMenB) is effective for preventing invasive meningococcal disease in children younger than 5 years, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news